ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 100 filers reported holding ANTARES PHARMA INC in Q2 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,374,000 | +3.0% | 334,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,334,000 | +44.7% | 334,300 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $922,000 | -7.5% | 341,300 | -5.8% | 0.00% | 0.0% |
| Q2 2020 | $997,000 | +17.4% | 362,471 | +0.8% | 0.00% | 0.0% |
| Q1 2020 | $849,000 | -49.1% | 359,571 | +1.3% | 0.00% | -50.0% |
| Q4 2019 | $1,668,000 | +94.9% | 354,871 | +38.6% | 0.00% | +100.0% |
| Q3 2019 | $856,000 | +23.3% | 255,971 | +21.3% | 0.00% | 0.0% |
| Q2 2019 | $694,000 | -53.1% | 210,995 | -56.8% | 0.00% | -50.0% |
| Q1 2019 | $1,481,000 | +11.4% | 488,795 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,330,000 | -19.0% | 488,795 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,642,000 | +31.6% | 488,795 | +1.1% | 0.00% | 0.0% |
| Q2 2018 | $1,248,000 | -29.5% | 483,600 | -39.9% | 0.00% | -33.3% |
| Q1 2018 | $1,771,000 | +10.5% | 805,200 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $1,602,000 | -49.2% | 805,200 | -17.2% | 0.00% | -60.0% |
| Q3 2017 | $3,152,000 | +4.8% | 972,694 | +4.1% | 0.01% | 0.0% |
| Q2 2017 | $3,008,000 | +13.4% | 934,300 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $2,653,000 | +39.3% | 934,300 | +14.4% | 0.00% | +33.3% |
| Q4 2016 | $1,904,000 | +277.8% | 817,000 | +172.4% | 0.00% | +200.0% |
| Q3 2016 | $504,000 | +49.6% | 299,900 | -6.4% | 0.00% | 0.0% |
| Q2 2016 | $337,000 | +17.0% | 320,500 | -3.0% | 0.00% | – |
| Q1 2016 | $288,000 | -32.1% | 330,500 | -5.7% | 0.00% | -100.0% |
| Q4 2015 | $424,000 | -28.9% | 350,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $596,000 | -21.0% | 350,400 | -3.3% | 0.00% | 0.0% |
| Q2 2015 | $754,000 | -11.4% | 362,300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $851,000 | 0.0% | 362,300 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $851,000 | +28.4% | 362,300 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $663,000 | -31.4% | 362,300 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $967,000 | -18.3% | 362,300 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $1,184,000 | -21.3% | 362,300 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,504,000 | +1.1% | 362,300 | -1.2% | 0.00% | -33.3% |
| Q3 2013 | $1,488,000 | +9.9% | 366,600 | +12.7% | 0.00% | 0.0% |
| Q2 2013 | $1,354,000 | – | 325,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |